Cephalexin labels and packages
| Cephalexin |
|---|
| CEPHALEXIN®,KEFLEX® FDA Package Insert |
| Description |
| Clinical Pharmacology |
| Microbiology |
| Indications and Usage |
| Contraindications |
| Warnings and Precautions |
| Adverse Reactions |
| Overdosage |
| Dosage and Administration |
| How Supplied |
| Labels and Packages |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Abdurahman Khalil, M.D. [2]
TEVA PHARMACEUTICALS USA
Sellersville, PA 18960
Rev. Q 1/2012
PRINCIPAL DISPLAY PANEL
 |
Cephalexin Capsules USP 250 mg 100s Label Text
NDC 0093-3145-01
CEPHALEXIN
Capsules USP
250 mg*
Rx only
100 CAPSULES
TEVA
PRINCIPAL DISPLAY PANEL
 |
Cephalexin Capsules USP 500 mg 100s Label Text
NDC 0093-3147-01
CEPHALEXIN
Capsules USP
500 mg*
Rx only
100 CAPSULES
TEVA
PRINCIPAL DISPLAY PANEL
 |
Cephalexin FOS USP 125 mg per 5 mL 100 mL Label Text
NDC 0093-4175-73
CEPHALEXIN
for Oral Suspension, USP
125 mg per 5 mL
when reconstituted according to directions.
Usual Pediatric Dose: 25 to 50 mg per kg a day in four
divided doses. For more severe infections, dose may be
doubled. See accompanying literature.
Rx only
FOR ORAL USE ONLY
100 mL (when mixed)
TEVA
PRINCIPAL DISPLAY PANEL
 |
Cephalexin FOS USP 250 mg per 5 mL 100 mL Label Text
NDC 0093-4177-73
CEPHALEXIN
for Oral Suspension, USP
250 mg per 5 mL
when reconstituted according to directions.
Usual Pediatric Dose: 25 to 50 mg per kg a day in four
divided doses. For more severe infections, dose may be
doubled. See accompanying literature.
Rx only
FOR ORAL USE ONLY
100 mL (when mixed)
TEVA
PRINCIPAL DISPLAY PANEL
 |
Cephalexin Tablets USP 250 mg 100s Label Text
NDC 0093-2238-01
CEPHALEXIN
Tablets USP
250 mg*
Rx only
100 TABLETS
TEVA
PRINCIPAL DISPLAY PANEL
 |
Cephalexin Tablets USP 500 mg 100s Label Text NDC 0093-2240-01
CEPHALEXIN
Tablets USP
500 mg*
Rx only
100 TABLETS
TEVA
References
http://www.accessdata.fda.gov/drugsatfda_docs/label/2006/050405s097lbl.pdf